Altor BioScience's Series D Round

Altor BioScience raised a round of funding on January 05, 2011.

Altor BioScience is a biopharmaceutical company engaged in the discovery, development and commercialization of high-value, targeted immunotherapeutic agents for the treatment of cancer, viral infectio…

Articles about Altor BioScience's Series D Round: